142 related articles for article (PubMed ID: 37390984)
1. High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs.
Knezevic L; Wachsmann TLA; Francis O; Dockree T; Bridgeman JS; Wouters A; de Wet B; Cole DK; Clement M; McLaren JE; Gostick E; Ladell K; Llewellyn-Lacey S; Price DA; van den Berg HA; Tabi Z; Sessions RB; Heemskerk MHM; Wooldridge L
J Biol Chem; 2023 Aug; 299(8):104981. PubMed ID: 37390984
[TBL] [Abstract][Full Text] [Related]
2. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
[TBL] [Abstract][Full Text] [Related]
3. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.
Wooldridge L; Clement M; Lissina A; Edwards ES; Ladell K; Ekeruche J; Hewitt RE; Laugel B; Gostick E; Cole DK; Debets R; Berrevoets C; Miles JJ; Burrows SR; Price DA; Sewell AK
J Immunol; 2010 Apr; 184(7):3357-66. PubMed ID: 20190139
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.
Wooldridge L; Hutchinson SL; Choi EM; Lissina A; Jones E; Mirza F; Dunbar PR; Price DA; Cerundolo V; Sewell AK
J Immunol; 2003 Dec; 171(12):6650-60. PubMed ID: 14662868
[TBL] [Abstract][Full Text] [Related]
6. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.
Hutchinson SL; Wooldridge L; Tafuro S; Laugel B; Glick M; Boulter JM; Jakobsen BK; Price DA; Sewell AK
J Biol Chem; 2003 Jul; 278(27):24285-93. PubMed ID: 12697765
[TBL] [Abstract][Full Text] [Related]
7. CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor.
Clement M; Knezevic L; Dockree T; McLaren JE; Ladell K; Miners KL; Llewellyn-Lacey S; Rubina A; Francis O; Cole DK; Sewell AK; Bridgeman JS; Price DA; van den Berg HA; Wooldridge L
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34272276
[TBL] [Abstract][Full Text] [Related]
8. CD8
Dockree T; Holland CJ; Clement M; Ladell K; McLaren JE; van den Berg HA; Gostick E; L Miners K; Llewellyn-Lacey S; Bridgeman JS; Man S; Bailey M; Burrows SR; Price DA; Wooldridge L
Immunol Cell Biol; 2017 Jan; 95(1):68-76. PubMed ID: 27670790
[TBL] [Abstract][Full Text] [Related]
9. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
[TBL] [Abstract][Full Text] [Related]
10. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
11. Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.
Melenhorst JJ; Scheinberg P; Chattopadhyay PK; Lissina A; Gostick E; Cole DK; Wooldridge L; van den Berg HA; Bornstein E; Hensel NF; Douek DC; Roederer M; Sewell AK; Barrett AJ; Price DA
J Immunol Methods; 2008 Sep; 338(1-2):31-9. PubMed ID: 18675271
[TBL] [Abstract][Full Text] [Related]
12. Coreceptor CD8-driven modulation of T cell antigen receptor specificity.
van den Berg HA; Wooldridge L; Laugel B; Sewell AK
J Theor Biol; 2007 Nov; 249(2):395-408. PubMed ID: 17869274
[TBL] [Abstract][Full Text] [Related]
13. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
Wooldridge L; Scriba TJ; Milicic A; Laugel B; Gostick E; Price DA; Phillips RE; Sewell AK
Eur J Immunol; 2006 Jul; 36(7):1847-55. PubMed ID: 16783852
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.
Wooldridge L; van den Berg HA; Glick M; Gostick E; Laugel B; Hutchinson SL; Milicic A; Brenchley JM; Douek DC; Price DA; Sewell AK
J Biol Chem; 2005 Jul; 280(30):27491-501. PubMed ID: 15837791
[TBL] [Abstract][Full Text] [Related]
15. Targeted suppression of autoreactive CD8
Clement M; Pearson JA; Gras S; van den Berg HA; Lissina A; Llewellyn-Lacey S; Willis MD; Dockree T; McLaren JE; Ekeruche-Makinde J; Gostick E; Robertson NP; Rossjohn J; Burrows SR; Price DA; Wong FS; Peakman M; Skowera A; Wooldridge L
Sci Rep; 2016 Oct; 6():35332. PubMed ID: 27748447
[TBL] [Abstract][Full Text] [Related]
16. An active CD8alpha/pMHCI interaction is required for CD8 single positive thymocyte differentiation.
Kang YJ; Wang X; Lin SJ; Hsu YM; Chang HC
Eur J Immunol; 2010 Mar; 40(3):836-48. PubMed ID: 19950178
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
Clement M; Ladell K; Ekeruche-Makinde J; Miles JJ; Edwards ES; Dolton G; Williams T; Schauenburg AJ; Cole DK; Lauder SN; Gallimore AM; Godkin AJ; Burrows SR; Price DA; Sewell AK; Wooldridge L
J Immunol; 2011 Jul; 187(2):654-63. PubMed ID: 21677135
[TBL] [Abstract][Full Text] [Related]
18. V-CARMA: A tool for the detection and modification of antigen-specific T cells.
Guo XJ; Elledge SJ
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042811
[TBL] [Abstract][Full Text] [Related]
19. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
Baumgaertner P; Schmidt J; Costa-Nunes CM; Bordry N; Guillaume P; Luescher I; Speiser DE; Rufer N; Hebeisen M
Front Immunol; 2022; 13():973986. PubMed ID: 36032094
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
Wooldridge L; Lissina A; Vernazza J; Gostick E; Laugel B; Hutchinson SL; Mirza F; Dunbar PR; Boulter JM; Glick M; Cerundolo V; van den Berg HA; Price DA; Sewell AK
Eur J Immunol; 2007 May; 37(5):1323-33. PubMed ID: 17429845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
